Efficacy and Prognostic Factors of Docetaxel Rechallenge on Metastatic Castration-resistant Prostate Cancer Patients

Efficacy and Prognostic Factors of Docetaxel Rechallenge on Metastatic Castration-resistant Prostate Cancer Patients

Objective To assess the efficacy of docetaxel rechallenge on castration-resistant prostate cancer (mCRPC) patients and to analyze prognostic factors. Methods We retrospectively reviewed the medical history of 120 mCRPC patients treated with the first-line docetaxel chemotherapy effectively and progr...

Full description

Bibliographic Details
Main Authors: DUAN Liqun, ZHANG Qu, LIU Sanhe, DENG Kangli, WEI Shaozhong
Format: Article
Language:zho
Published: Magazine House of Cancer Research on Prevention and Treatment 2019-09-01
Series:Zhongliu Fangzhi Yanjiu
Subjects:
docetaxel
metastatic castration-resistant prostate cancer
efficacy
prognostic factor
Online Access:http://html.rhhz.net/ZLFZYJ/html/8578.2019.19.0626.htm

Internet

http://html.rhhz.net/ZLFZYJ/html/8578.2019.19.0626.htm

Similar Items